Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion‐independent thalassemia intermedia compared to regularly transfused thalassemia major patients
2009; Wiley; Volume: 85; Issue: 4 Linguagem: Inglês
10.1002/ajh.21626
ISSN1096-8652
AutoresAlì Taher, Khaled M. Musallam, John C. Wood, Maria Domenica Cappellini,
Tópico(s)Iron Metabolism and Disorders
ResumoAmerican Journal of HematologyVolume 85, Issue 4 p. 288-290 LetterFree Access Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients† Ali T. Taher, Corresponding Author Ali T. Taher [email protected] Hematology-Oncology Division, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh 1107 2020, Beirut, LebanonSearch for more papers by this authorKhaled M. Musallam, Khaled M. Musallam Hematology-Oncology Division, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, LebanonSearch for more papers by this authorJohn C. Wood, John C. Wood Division of Pediatric Cardiology, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California Division of Radiology, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CaliforniaSearch for more papers by this authorMaria Domenica Cappellini, Maria Domenica Cappellini Department of Internal Medicine, Universitá di Milano, Policlinico Foundation, IRCCS, Milan, ItalySearch for more papers by this author Ali T. Taher, Corresponding Author Ali T. Taher [email protected] Hematology-Oncology Division, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, LebanonDepartment of Internal Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh 1107 2020, Beirut, LebanonSearch for more papers by this authorKhaled M. Musallam, Khaled M. Musallam Hematology-Oncology Division, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, LebanonSearch for more papers by this authorJohn C. Wood, John C. Wood Division of Pediatric Cardiology, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California Division of Radiology, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CaliforniaSearch for more papers by this authorMaria Domenica Cappellini, Maria Domenica Cappellini Department of Internal Medicine, Universitá di Milano, Policlinico Foundation, IRCCS, Milan, ItalySearch for more papers by this author First published: 23 December 2009 https://doi.org/10.1002/ajh.21626Citations: 43 † Conflict of interest: ATT and MDC are members of Novartis Speakers' Bureau. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Taher A,Ismaeel H,Cappellini MD. Thalassaemia intermedia: Revisited. Blood Cells Mol Dis 2006; 37: 12– 20. 2 Kleber FX,Niemoller L,Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: Results of the Munich mild heart failure trial. Br Heart J 1992; 67: 289– 296. 3 St Pierre TG,Clark PR,Chua-anusorn W. Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Ann N Y Acad Sci 2005; 1054: 379– 385. 4 Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol 2007; 14: 183– 190. 5 Origa R,Galanello R,Ganz T, et al. Liver iron concentrations and urinary hepcidin in b-thalassemia. Haematologica 2007; 92: 583– 588. 6 Taher A,El RF,Isma'eel H, et al. Correlation of liver iron concentration determined by R2 MRI with serum ferritin in patients with thalassemia intermedia. Haematologica 2008; 93: 1584– 1585. 7 Pakbaz Z,Fischer R,Fung E, et al. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients. Pediatr Blood Cancer 2007; 49: 329– 332. 8 Kearney SL,Nemeth E,Neufeld EJ, et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 2007; 48: 57– 63. 9 Kattamis A,Papassotiriou I,Palaiologou D, et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006; 91: 809– 812. 10 Origa R,Barella S,Argiolas GM, et al. No evidence of cardiac iron in 20 never or minimally transfused patients with thalassemia intermedia. Haematologica 2008; 93: 1095– 1096. 11 Chirnomas SD,Geukes-Foppen M,Barry K, et al. Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias. Am J Hematol 2008; 83: 781– 783. 12 Mavrogeni S,Gotsis E,Ladis V, et al. Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major. Int J Cardiovasc Imaging 2008; 24: 849– 854. 13 Voskaridou E,Douskou M,Terpos E, et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 2004; 126: 736– 742. 14 Au WY,Lam WWM,Chu WWC, et al. Organ-specific hemosiderosis and functional correlation in Chinese patients with thalassemia intermedia and hemoglobin H disease. Ann Hematol 2009; 88: 947– 950. 15 Lombardo T,Tamburino C,Bartoloni G, et al. Cardiac iron overload in thalassemic patients: An endomyocardial biopsy study. Ann Hematol 1995; 71: 135– 141. 16 Sonakul D,Thakerngpol K,Pacharee P. Cardiac pathology in 76 thalassemic patients. Birth Defects Orig Artic Ser 1988; 23: 177– 191. 17 Link G,Pinson A,Hershko C. Heart cells in culture: A model of myocardial iron overload and chelation. J Lab Clin Med 1985; 106: 147– 153. 18 Nathan DG. Thalassemia: The continued challenge. Ann N Y Acad Sci 2005; 1054: 1– 10. 19 Wood JC. Cardiac iron across different transfusion-dependent diseases. Blood Rev 2008; 22: S14– S21. 20 Noetzli LJ,Carson SM,Nord AS, et al. Longitudinal analysis of heart and liver iron in thalassemia major. Blood 2008; 112: 2973– 2978. 21 Wood JC,Tyszka JM,Carson S, et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004; 103: 1934– 1936. 22 Jensen PD,Jensen FT,Christensen T, et al. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: Indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003; 101: 4632– 4639. Citing Literature Volume85, Issue4April 2010Pages 288-290 ReferencesRelatedInformation
Referência(s)